生物活性 | |||
---|---|---|---|
描述 | ARV-766 is identified as an orally available and potent PROTAC that targets the degradation of both the wild-type androgen receptor (AR) and key AR LBD mutants, specifically the prevalent AR L702H, H875Y, and T878A mutations[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.24mL 0.25mL 0.12mL |
6.19mL 1.24mL 0.62mL |
12.38mL 2.48mL 1.24mL |
参考文献 |
---|